SC 13G

Company

LIPELLA PHARMACEUTICALS INC.

Filed

February 9, 2023

Accession Number

0001753926-23-000113

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →